A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report - Image 1

£67.83

National Academies Press A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

Name: A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
Brand: National Academies Press
Price: 67.83 GBP
Availability: InStock

Infectious & Contagious Diseases

About as cheap as it gets. The only time it was cheaper was 1 month ago.

£68 today · all-time low £68 (Jun 2026) · usually £68

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 82 days · 82 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 82 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £96 (43 days, 52.4%)

Price range: £68 - £96

Price levels: 2 different prices over 82 days

Description

Hepatitis B and C cause most cases of hepatitis in the United States and the world. The two diseases account for about a million deaths a year and 78 percent of worlda (TM)s hepatocellular carcinoma and more than half of all fatal cirrhosis. In 2013 viral hepatitis, of which hepatitis B virus (HBV) and hepatitis C virus (HCV) are the most common types, surpassed HIV and AIDS to become the seventh leading cause of death worldwide. The world now has the tools to prevent hepatitis B and cure hepatitis C. Perfect vaccination could eradicate HBV, but it would take two generations at least. In the meantime, there is no cure for the millions of people already infected. Conversely, there is no vaccine for HCV, but new direct-acting antivirals can cure 95 percent of chronic infections, though these drugs are unlikely to reach all chronically-infected people anytime soon. This report, the second of two, builds off the conclusions of the first report and outlines a strategy for hepatitis reduction over time and specific actions to achieve them.

Product Specifications

Brand: National Academies Press
Format: paperback
ASIN: 0309457297
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Internal Medicine > Diseases & Disorders > Infectious & Contagious Diseases
Domain: Amazon UK
Release Date: 30 June 2017
Listed Since: 01 April 2017

Barcode

No barcode data available

National Academies Press A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report

About as cheap as it gets. The only time it was cheaper was 1 month ago.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Hepatitis B and C: Management and Treatment

Chronic Viral Hepatitis: Management and Control

Viral Hepatitis

Hepatitis C Virus II: Infection and Disease: 2

The Molecular Medicine of Viral Hepatitis (Molecular Medical Science Series)

Viral Hepatitis Molecular Biology Diagnosis and Control (Volume 10) (Perspectives in Medical Virology, Volume 10)

Hepatitis C Virus: From Laboratory to Clinic

Hepatitis B Research Advances

Hepatitis C Infection as a Systemic Disease:Extra-HepaticManifestation of Hepatitis C, An Issue of Clinics in Liver Disease (Volume 21-3) (The Clinics: Internal Medicine, Volume 21-3)

Hepatitis B Virus in Human Diseases (Molecular and Translational Medicine)

The Hepatitis C Viruses: 242 (Current Topics in Microbiology and Immunology, 242)

Hepatitis B: The Virus, the Disease, and the Vaccine

Studies on Hepatitis Viruses: Life Cycle, Structure, Functions, and Inhibition

Academic Press - Comprehensive Guide to Hepatitis Advances

Overcoming Barriers to Eliminate Hepatitis C, An Issue of Infectious Disease Clinics of North America (Volume 32-2) (The Clinics: Internal Medicine, Volume 32-2)

Hepatitis: An Issue of Clinics in Liver Disease

Hepatitis C: Methods and Protocols: 510 (Methods in Molecular Biology, 510)